M. Bruhn

发表

Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer

V. Gebski, J. Simes, D. Cunningham, 2015, British Journal of Cancer.

High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab

Y. Tomita, T. Price, J. Hardingham, 2017, Clinical and Translational Oncology.

Correlation of PI3KCA and extended RAS gene mutation status with outcomes from the phase III AGITG MAX involving capecitabine (C) alone or in combination with bevacizumab (B) with or without mitomycin C (M) in advanced colorectal cancer (CRC).

V. Gebski, J. Simes, D. Cunningham, 2014 .

511PMOLECULAR SUBGROUPS FROM THE AGITG MAX TRIAL; RIGHT OR LEFT PRIMARY SITE OF COLORECTAL CANCER AND OUTCOMES FOR METASTATIC COLORECTAL CANCER (MCRC).

V. Gebski, R. Simes, T. Price, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer

V. Gebski, J. Mariadason, J. Simes, 2022, Scientific Reports.

Nasal Mucosa Expression of Lactoferrin in Patients With Chronic Rhinosinusitis

E. Ooi, P. Wormald, A. Psaltis, 2007, The Laryngoscope.

Response of Peripheral Blood Lymphocytes to Fungal Extracts and Staphylococcal Superantigen B in Chronic Rhinosinusitis

R. Douglas, E. Ooi, P. Wormald, 2007, The Laryngoscope.

Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro

A. Evdokiou, T. Price, J. Hardingham, 2016, Journal of Experimental & Clinical Cancer Research.

AKT-independent PI3-K signaling in cancer – emerging role for SGK3

R. Pearson, R. Hannan, K. Sheppard, 2013, Cancer management and research.

Second AKT: The rise of SGK in cancer signalling

R. Pearson, R. Hannan, K. Sheppard, 2010, Growth factors.

Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002.

C. Grau, J. Overgaard, C. Godballe, 2013, European journal of cancer.

Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer

D. Cunningham, T. Price, N. Tebbutt, 2014, International journal of cancer.

Fast track for head and neck cancer patients: The story of the Danish national strategy for accelerated diagnosis and treatment of cancer

C. Grau, J. Overgaard, C. Godballe, 2011 .